CMTG vs XFOR
Comparison between Claros Mortgage Trust Inc (CMTG, Company) and X4 Pharmaceuticals Inc (XFOR, Company).
CMTG is from the Real Estate sector, while XFOR is from the Healthcare sector.
5-Year PerformanceCMTG has outperformed XFOR, delivering a return of -29.4% compared to -56.7%
CMTG vs XFOR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CMTG vs XFOR - Historical Returns
Returns include dividend reinvestment.
CMTG vs XFOR - Annual Returns (2017 - 2026)
Returns include dividend reinvestment.
| Year | CMTG | XFOR |
|---|---|---|
| 2026 | -17.80% | +2.83% |
| 2025 | -29.49% | -82.27% |
| 2024 | -64.76% | -16.84% |
| 2023 | +1.46% | -12.35% |
| 2022 | -1.96% | -61.51% |
| 2021 | -1.32% | -65.46% |
| 2020 | N/A | -41.28% |
| 2019 | N/A | -30.34% |
| 2018 | N/A | -80.65% |
| 2017 | N/A | -9.05% |
CMTG vs XFOR Drawdown Comparison
The maximum drawdown for CMTG was -87.09%, occurring on Mar 20, 2026. This drawdown has not yet recovered.
The maximum drawdown for XFOR was -99.97%, occurring on Aug 11, 2025. This drawdown has not yet recovered.
The current CMTG drawdown is -84.23%. The current XFOR drawdown is -99.91%.
| Rank | CMTG | XFOR |
|---|---|---|
| #1 | -87.09% Jun 3, 2022 - Mar 20, 2026 | -99.97% Mar 20, 2018 - Aug 11, 2025 |
| #2 | -15.53% Dec 3, 2021 - Jan 11, 2022 | -41.18% Nov 28, 2017 - Mar 13, 2018 |
| #3 | -11.91% Jan 18, 2022 - Apr 7, 2022 | -6.41% Mar 15, 2018 - Mar 20, 2018 |
| #4 | -10.95% Apr 25, 2022 - May 10, 2022 | -0.71% Nov 16, 2017 - Nov 20, 2017 |
| #5 | -5.32% Nov 18, 2021 - Dec 2, 2021 | N/A |
| #6 | -3.10% May 23, 2022 - Jun 3, 2022 | N/A |
| #7 | -2.58% Nov 5, 2021 - Nov 16, 2021 | N/A |
| #8 | -2.25% May 12, 2022 - May 16, 2022 | N/A |
| #9 | -2.09% Apr 7, 2022 - Apr 18, 2022 | N/A |
| #10 | -1.40% May 16, 2022 - May 20, 2022 | N/A |
| #11 | -1.04% Jan 12, 2022 - Jan 18, 2022 | N/A |
Correlation
Correlation between CMTG and XFOR is 0.71 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks